SCHEMBL6389597

SCHEMBL6389597

Cc1ccc2c3c(cc(S(=O)(=O)O)cc13)C(=O)OC2=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ PABPC1 P11940 1/20 0.39
▸ TYMS P04818 6/20 0.38
▸ MEN1 O00255 2/20 0.33
▸ RECQL P46063 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ THRB P10828 1/20 0.33
▸ APEX1 P27695 1/20 0.33
▸ BLM P54132 1/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CASP6 P55212 1/20 0.33
▸ NSD2 O96028 2/20 0.32
▸ ENPP3 O14638 1/20 0.32
▸ ENTPD3 O75355 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6389483 0.84 TIMP3 (0.39) SMN1; SMN2MAPTTYMSMEN1RECQL
SCHEMBL6392749 0.83 TYMS (0.36) SMN1; SMN2MAPTTYMSMEN1RECQL
SCHEMBL6390766 0.82 TYMS (0.35) TYMSMEN1RECQLKMT2ATDP1
SCHEMBL6386946 0.82 TYMS (0.35) TYMSMEN1RECQLKMT2ATDP1
SCHEMBL6389093 0.81 TYMS (0.40) SMN1; SMN2TYMSMEN1RECQLKMT2A
SCHEMBL6393874 0.80 ELANE (0.35) MAPTKDM4ETYMSMEN1KMT2A
SCHEMBL6395149 0.79 ELANE (0.36) TYMSCYP2C19CYP1A2GABRA1GABRB2
SCHEMBL6390867 0.78 ELANE (0.38) SMN1; SMN2MAPTKDM4ETYMSMEN1
SCHEMBL6390629 0.77 TYMS (0.38) SMN1; SMN2MAPTKDM4ETYMSTDP1
SCHEMBL6390636 0.77 ALDH1A1 (0.40) SMN1; SMN2TYMSHSD17B10ALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050040373-A1 Dopant and conductive polymer material therewith MITSUI CHEMICALS, INC. (JP) 2005-02-24 — — US disclosed
US-6814888-B2 FOR PRODUCING SOLID ELECTROLYTIC CAPACITOR MITSUI CHEMICALS, INC. (JP) 2004-11-09 — — US disclosed
US-20030142462-A1 Dopant agent and electroconductive polymer material comprising the same MITSUI CHEMICALS, INC. (JP) 2003-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030142462-A1 Dopant agent and electroconductive polymer material comprising the same RPS6, H1-10, H1-0 SMN1; SMN2 1659/4885MAPT 1875/4885KDM4E 1906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback